A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.
about
Aripiprazole versus other atypical antipsychotics for schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaPractical clinical trials in psychopharmacology: a systematic reviewIdentification of Adverse Drug Events from Free Text Electronic Patient Records and Information in a Large Mental Health Case RegisterSimultaneous Comparison of Efficacy and Tolerability of Second-Generation Antipsychotics in Schizophrenia: Mixed-Treatment Comparison Analysis Based on Head-to-Head Trial DataThe effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Almost all antipsychotics result in weight gain: a meta-analysis.Two cases of hypersexuality probably associated with aripiprazole.A review of the safety and tolerability of aripiprazole.A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole.Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind ComparisonEffect of antipsychotic medications on glucose and lipid levels.Atypical antipsychotic tolerability and switching strategies in bipolar disorder.Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment.Aripiprazole: a review of its use in the management of schizophrenia in adults.The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia.Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists.Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors.Defining the minimal clinically important difference (MCID) of the Heinrichs-carpenter quality of life scale (QLS).Antipsychotic effects of quetiapine in naturalistic long term follow up study.Is the GABA System Related to the Social Competence Improvement Effect of Aripiprazole? An (18)F-Fluoroflumazenil PET Study.Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis.Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia.Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia.Understanding antipsychotic-induced weight gain and other metabolic issues
P2860
Q24200904-8E2EC939-3691-4669-89B6-493BA963D187Q24201232-70923D36-3316-44D1-B745-A066881D1357Q27021467-5470ACD4-89DE-44ED-824D-73FF76C35A11Q28547303-1DB72053-43A7-4279-A1EC-699AB98D9209Q28651174-1D30F164-2EE6-4B2E-96BC-0A9D74EF3306Q33395073-0D838A00-A6BD-44D7-9948-7102567BA4B1Q33518314-6329B111-0AC8-4964-9DB8-AAF857410D5CQ33619940-F7816C34-06C5-4DF4-B4DB-BDFF1421A661Q34011162-4C4C03A5-5D3F-4C18-878B-D34852306036Q34174609-B9D520D7-37EE-490E-BE17-BF3CB5603026Q34640811-3F9BFDA2-BC55-4557-8087-DBACA52872FCQ34661499-ADA1996D-6FAF-46B5-9E49-039E3E4AC182Q36941598-7FFFD423-6444-4995-AED5-609F46C015E8Q37510958-805EF922-7B31-47D5-BABC-C987EC2A952AQ37531967-B67BBD00-1449-401D-985F-F7880F689D98Q37687951-A626F08E-EE8F-4B0D-9048-2165D9ADF94DQ37735606-09702347-3BAF-4D7A-BFCC-B992C3D51234Q37781370-AE358F3E-A922-4B38-A69E-6BF299844A88Q37947687-2CECB2EF-E533-418B-AC08-848BB9ACA99CQ37980517-5121CB30-F61F-4383-9BBA-B7825F94E06EQ38113746-74E546A0-86BC-49F4-B83A-6B4B770E60D0Q38352080-A1DBFA28-AF40-452B-9CE3-F01705A56538Q39852066-E09F3C4D-81CF-4767-ACC8-A440AF05B4A8Q40664835-7576A50D-193B-4B84-A72F-ADD2F5E9D6ABQ41361163-2AC41951-7FCF-4D18-AE41-F5E04C833FF5Q41513402-F421B837-A5D2-42C2-9A3E-A1538E678802Q42650536-5451C31C-FE97-4763-984B-14CBD475C130Q47587816-A89323BF-A815-4C65-AA22-3E74E45556BCQ47827614-63AE5867-5E97-4168-98E4-057EFCD623D9Q50739337-21A4C117-6263-40A1-924D-0BEA8B38AC0BQ58201746-589FCEA3-9D73-492D-9291-B9D2C28B0DDE
P2860
A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
A multicentre, randomized, nat ...... of Aripiprazole: (STAR) study.
@en
A multicentre, randomized, nat ...... of Aripiprazole: (STAR) study.
@nl
type
label
A multicentre, randomized, nat ...... of Aripiprazole: (STAR) study.
@en
A multicentre, randomized, nat ...... of Aripiprazole: (STAR) study.
@nl
prefLabel
A multicentre, randomized, nat ...... of Aripiprazole: (STAR) study.
@en
A multicentre, randomized, nat ...... of Aripiprazole: (STAR) study.
@nl
P2093
P921
P1433
P1476
A multicentre, randomized, nat ...... of Aripiprazole: (STAR) study.
@en
P2093
Bruno Millet
Csaba M Banki
Erik Herman
Gilbert L'Italien
Henrik Lublin
Jean-Noël Beuzen
Linda Hanssens
Miranda Pans
Robert D McQuade
Robert Kerwin
P304
P356
10.1016/J.EURPSY.2007.03.002
P407
P577
2007-06-07T00:00:00Z